platinum has been researched along with tretinoin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Culp, DA; Loening, SA; Narayana, AS | 1 |
| Bugat, R; Caliaro, MJ; Canal, P; Jozan, S; Lafon, C; Lochon, I; Néhmé, A; Valette, A; Vitaux, P | 1 |
| Gurunathan, S; Jeyaraj, M; Kang, MH; Kim, JH | 1 |
3 other study(ies) available for platinum and tretinoin
| Article | Year |
|---|---|
Bladder carcinoma at University of Iowa Hospital and Clinics.
Topics: Antineoplastic Agents; Female; Hospitals, University; Humans; Male; Platinum; Tretinoin; Urinary Bladder Neoplasms | 1978 |
Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; DNA Adducts; DNA Primers; Drug Synergism; ErbB Receptors; Female; Glutathione; Glutathione Transferase; Humans; Kinetics; Metallothionein; Ovarian Neoplasms; Platinum; Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1997 |
Anticancer Properties of Platinum Nanoparticles and Retinoic Acid: Combination Therapy for the Treatment of Human Neuroblastoma Cancer.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; beta Carotene; Cell Differentiation; Cell Division; Cell Line, Tumor; Cisplatin; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Drug Synergism; Endoplasmic Reticulum Stress; Humans; L-Lactate Dehydrogenase; Membrane Potential, Mitochondrial; Metal Nanoparticles; Neoplasm Proteins; Neuroblastoma; Oxidative Stress; Peptide Hydrolases; Platinum; Tretinoin | 2020 |